Advertisement

Topics

Prime Therapeutics, Inc. Company Profile

20:25 EST 18th November 2017 | BioPortfolio


News Articles [868 Associated News Articles listed on BioPortfolio]

Prime Therapeutics Study Finds A Diabetes Drugs Value Based Insurance Design Improves Adherence, Doesn't Lower Total Cost Of Care

ST. PAUL, Minn., Oct. 13, 2017 /PRNewswire/ --Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving more than 20 million members nationally, found that implementing value based insu...

Five Prime’s Williams to Transition from CEO to Executive Chairman

Five Prime Therapeutics (NASDAQ: FPRX) announced that founder Lewis “Rusty” Williams plans to transition from CEO to executive chairman next year. Williams founded South San Francisco, CA-based Fi...

Five Prime Therapeutics Promotes Aron Knickerbocker to CEO

Five Prime Therapeutics (NASDAQ: FPRX) did not have to go far to find its next CEO. Aron Knickerbocker, currently the chief operating officer of the South San Francisco, CA, biotech, has been named it...

Five Prime Therapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 13062017] Prices from USD $350

Five Prime Therapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Five Prime Therapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliance...

Five Prime Therapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 17102017] Prices from USD $350

Five Prime Therapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Five Prime Therapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliance...

Experimental sickle cell disease drug gets PRIME status

Global Blood Therapeutics’ GBT440 has become the first potential treatment for sickle cell disease to be accepted onto the European Medicines Agency’s regulatory support programme PRIME.

Five Prime Therapeutics Presents Initial Clinical Trial Data from Phase 1/2 trial of Cabiralizumab in Pigmented Villonodular Synovitis (PVNS) at 2017 ASCO Annual Meeting

SOUTH SAN FRANCISCO, Calif., June 04, 2017 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX) announced that a poster featuring initial clinical data from the ongoing Phase 1/2 clinical t...

The 10 best Prime Day 2017 TV deals

As is the case with Black Friday each year, TV deals have become a huge focus of Amazon's massive annual Prime Day shopping event. Of course, Prime Day 2017 is no different, and there are a slew o...

PubMed Articles [522 Associated PubMed Articles listed on BioPortfolio]

To Prime or Not to Prime - Is That Still a Question? A Comment on the US Guidelines on Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents.

Effect of Prime Blood Storage Duration on Clinical Outcome After Pediatric Cardiac Surgery.

In this study, we tested the hypothesis that in pediatric patients undergoing cardiac surgery using cardiopulmonary bypass (CPB) with blood prime, the storage duration of the packed red blood cells (P...

Improving Accuracy, Diversity, and Speed with Prime Macrocycle Conformational Sampling.

A novel method for exploring macrocycle conformational space, Prime Macrocycle Conformational Sampling (Prime-MCS), is introduced and evaluated in the context of other available algorithms (Molecular ...

Soluble F proteins exacerbate pulmonary histopathology after vaccination upon respiratory syncytial virus challenge but not when presented on virus-like particles.

Respiratory syncytial virus (RSV) fusion (F) protein is suggested to be a protective vaccine target although its efficacy and safety concerns remain not well understood. We investigated immunogenicity...

Osteosarcoma: A Diagnostic Dilemma.

Osteosarcoma is a primeval disease which is still partly understood. It is a malignancy of mesenchymal cells that have the capacity to generate osteoid or immature bone. There have been an abundance o...

Clinical Trials [241 Associated Clinical Trials listed on BioPortfolio]

XIENCE PRIME SV Everolimus Eluting Coronary Stent Post Marketing Surveillance (XIENCE PRIME SV PMS)

The objective of the study is to evaluate the safety and efficacy of XIENCE PRIME SV in real world practice in Japanese hospitals.

A Randomized Controlled Study Comparing Priming Solution Containing Crystalloid or Packed Red Blood Cells in Patients Treated With Isolated Limb Perfusion.

The primary aim of this study is to investigate the possibility to replace an erythrocyte based prime solution with a crystalloid based prime solution while maintaining metabolic function....

Comparison of Heterologous Prime-Boost Vaccination Schedules of Tetravalent Dengue Virus Purified Inactivated Vaccine (PIV) and Tetravalent Dengue Virus Live Attenuated Vaccine (LAV) in Healthy Adults in a Nonendemic Region

This study is a Phase 1, randomized, open-label study of the prime-boost vaccine candidates given in the prime-boost regimen previously demonstrated to have a high level of immunogenicity ...

Effects of Extra Corporeal Circuit Prime on Electrolytes Balance and Clinical Outcome Following Cardiac Surgery

About 6000 heart operations are performed in Sweden every year. A heart-lung machine is used almost exclusively in all heart operations. This machine fills the role of heart and lungs duri...

A Trial to Evaluate the Safety and Immunogenicity of TBC-M4, an Env, Gag, Tat-Rev, and Nef-RT MVA HIV Vaccine and a Prime-Boost Regimen With ADVAX, an Env, Gag, Nef-Tat and Pol DNA HIV Vaccine and TBC-M4

This trial will study a prime-boost vaccine approach designed mainly to induce cell-mediated immune (CTL) responses. Two vaccine candidates will be used in two different prime-boost regime...

Companies [1246 Associated Companies listed on BioPortfolio]

Prime Therapeutics LLC

Prime Therapeutics LLC (Prime) helps people get the medicine they need to feel better and live well. Prime manages pharmacy benefits for health plans, employers, and government pr...

Five Prime Therapeutics

Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases. Five Prime has develope...

Prime Health Services, Inc.

Founded in 1996 and based in Brentwood, TN, Prime Health Services (Prime Health) is a managed care company that offers a full spectrum of services, including a Preferred Provider ...

Prime Health Services Inc.

Founded in 1996 and based in Brentwood, TN, Prime Health Services (Prime Health) is a managed care company that offers a full spectrum of services, including a Preferred Provider ...

Five Prime Therapeutics, Inc.

Five Prime Therapeutics, Inc. is a clinical-stage, privately-held company discovering and developing innovative protein and antibody therapeutics. FivePrime is currently in Phase ...

More Information about "Prime Therapeutics, Inc." on BioPortfolio

We have published hundreds of Prime Therapeutics, Inc. news stories on BioPortfolio along with dozens of Prime Therapeutics, Inc. Clinical Trials and PubMed Articles about Prime Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Prime Therapeutics, Inc. Companies in our database. You can also find out about relevant Prime Therapeutics, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record